• Citer

The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients.

par Zielinski, Christoph C;Awada, Ahmad ;Cameron, David A;Cufer, T;Martin, Miguel;Aapro, Matty
Référence European journal of cancer, 44, 3, page (353-365)
Publication Publié, 2008-02

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients.
Auteur:	Zielinski, Christoph C; Awada, Ahmad; Cameron, David A; Cufer, T; Martin, Miguel; Aapro, Matty
Informations sur la publication:	European journal of cancer, 44, 3, page (353-365)
Statut de publication:	Publié, 2008-02
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Breast cancer
	EORTC
	European
	Febrile neutropenia
	G-CSF
	Granulocyte colony-stimulating factor
MeSH keywords:	Aged
	Antineoplastic Agents -- adverse effects
	Breast Neoplasms -- drug therapy
	Dose-Response Relationship, Drug
	Drug Administration Schedule
	Evidence-Based Medicine
	Female
	Granulocyte Colony-Stimulating Factor -- administration & dosage
	Humans
	Middle Aged
	Neutropenia -- chemically induced
	Neutropenia -- prevention & control
	Practice Guidelines as Topic
	Risk Assessment
	Risk Factors
	Treatment Outcome
Note générale:	Journal Article
	Review
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/j.ejca.2007.11.024
	info:pii/S0959-8049(07)00969-0
	info:scp/39149083085
	info:pmid/18191396